resveratrol has been researched along with cyclosporine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (41.67) | 29.6817 |
| 2010's | 11 (45.83) | 24.3611 |
| 2020's | 3 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Pan, CE; Wu, SL; Yu, L; Zhang, M | 1 |
| Chander, V; Chopra, K; Tirkey, N | 1 |
| Capasso, G; Chiodini, P; Della Ragione, F; Di Gennaro, CI; Galletti, P; Indaco, S; Manna, C; Migliardi, V; Zappia, V | 1 |
| Meng, KW; Pan, CE; Wu, SL; Yu, L | 1 |
| Storms, DH; Zunino, SJ | 1 |
| Pan, W; Quarles, LD; Song, LH; Xiao, ZS; Yu, YH; Zhou, HH | 1 |
| Ananthakrishnan, R; Caspersen, C; Gomez, T; Hwang, YC; Kaneko, M; Li, Q; Quadri, N; Ramasamy, R | 1 |
| Csiko, G; Csizinszky, R; Csordas, A; Domokos, M; Galfi, P; Jakus, J; Neogrady, Z; Szeker, K | 1 |
| Bian, HN; Brunk, UT; Song, R; Wang, X; Zhao, KS; Zhao, M | 1 |
| Junco, JJ; Kim, DJ; Liang, H; Malik, G; Mancha, A; Slaga, TJ; Wei, SJ | 1 |
| Anderson, RA; Panickar, KS; Qin, B | 1 |
| Carru, C; Cossu, A; Giordo, R; Hoa, PT; Nguyen, le HV; Pintus, G; Posadino, AM; Sotgia, S; Vardeu, A; Zinellu, A | 1 |
| Li, P; Song, R; Wang, X; Zhao, KS; Zhao, M | 1 |
| Keck, CM; Müller, RH; Romero, GB | 1 |
| Alan, H; Gul, M; Ozcan-Kucuk, A; Yolcu, U | 1 |
| Bekpinar, S; Bingul, I; Olgac, V; Uysal, M | 1 |
| Alp-Yıldırım, Fİ; Bekpinar, S; Cibali, E; Gultepe, S; Karaca, E; Olgac, V; Uydes-Doğan, BS; Uysal, M; Yamakoğlu, S | 1 |
| He, HN; Liu, X; Miao, YL; Schatten, H; Wu, DY; Xue, Z; Yin, SY; Zhang, X; Zhou, J | 1 |
| Cai, Y; Cao, Y; Chai, Y; Chen, L; Chen, X; Hong, Z; Liu, Y; Shi, Y; Wang, D; Zhu, Z | 1 |
24 other study(ies) available for resveratrol and cyclosporine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
[Effect of resveratrol alone and its combination with cyclosporin A on the immune function of human peripheral blood T lymphocytes].
Topics: Cyclosporine; Drug Synergism; Humans; Interferon-gamma; Interleukin-2; Lymphocyte Activation; Resveratrol; Stilbenes; T-Lymphocytes | 2003 |
Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism.
Topics: Animals; Antioxidants; Blood Pressure; Blood Urea Nitrogen; Creatinine; Cyclosporine; Enzyme Inhibitors; Immunosuppressive Agents; Kidney; Lipid Peroxidation; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Phytoalexins; Plant Extracts; Rats; Rats, Wistar; Resveratrol; Sesquiterpenes; Stilbenes; Terpenes; Weight Loss | 2005 |
Diverse effects of natural antioxidants on cyclosporin cytotoxicity in rat renal tubular cells.
Topics: Animals; Antioxidants; Cell Survival; Cells, Cultured; Cyclosporine; Epithelium; Fluoresceins; Glutathione; Kidney Diseases; Kidney Tubules, Proximal; Lipid Peroxides; Phenylethyl Alcohol; Rats; Rats, Inbred WKY; Reactive Oxygen Species; Resveratrol; Stilbenes; Thiobarbituric Acid Reactive Substances; Vitamin E | 2005 |
Immunosuppression by combined use of cyclosporine and resveratrol in a rat liver transplantation model.
Topics: Animals; Antioxidants; Cyclosporine; Drug Therapy, Combination; Graft Survival; Immunosuppression Therapy; Liver Transplantation; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Rats, Wistar; Resveratrol; Stilbenes | 2005 |
Resveratrol-induced apoptosis is enhanced in acute lymphoblastic leukemia cells by modulation of the mitochondrial permeability transition pore.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Isoquinolines; Jurkat Cells; Membrane Potentials; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Resveratrol; Stilbenes | 2006 |
Resveratrol prevents CsA inhibition of proliferation and osteoblastic differentiation of mouse bone marrow-derived mesenchymal stem cells through an ER/NO/cGMP pathway.
Topics: Animals; Bone Marrow Cells; Cell Differentiation; Cell Proliferation; Cyclic GMP; Cyclosporine; Dose-Response Relationship, Drug; Female; Mesenchymal Stem Cells; Mice; Nitric Oxide; Osteoblasts; Receptors, Estrogen; Resveratrol; Signal Transduction; Stilbenes | 2006 |
Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
Topics: Aldehyde Reductase; Animals; Antioxidants; Calcium; Cyclosporine; Deoxyglucose; Disease Models, Animal; Glutathione; Humans; Hydrogen Peroxide; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Swelling; Myocardial Reperfusion Injury; Myocardium; Reactive Oxygen Species; Resveratrol; Stilbenes | 2009 |
Butyrate-induced cell death and differentiation are associated with distinct patterns of ROS in HT29-derived human colon cancer cells.
Topics: Antioxidants; Apoptosis; Butyrates; Cell Adhesion; Cell Death; Cell Differentiation; Cell Division; Cyclosporine; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Free Radicals; HT29 Cells; Humans; Hydrogen Peroxide; Immunosuppressive Agents; In Situ Nick-End Labeling; Isoquinolines; Necrosis; Reactive Oxygen Species; Resveratrol; Stilbenes | 2010 |
Polydatin, a natural polyphenol, protects arterial smooth muscle cells against mitochondrial dysfunction and lysosomal destabilization following hemorrhagic shock.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cyclosporine; Cytoprotection; Glucosides; KATP Channels; Lysosomes; Membrane Potential, Mitochondrial; Mitochondria, Muscle; Mitochondrial Diseases; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Smooth Muscle; Norepinephrine; Rats; Resveratrol; Shock, Hemorrhagic; Stilbenes | 2012 |
Resveratrol and P-glycoprotein inhibitors enhance the anti-skin cancer effects of ursolic acid.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Survival; Cyclosporine; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Mice; Resveratrol; Rhodamine 123; Skin Neoplasms; Stilbenes; Triterpenes; Ursolic Acid; Verapamil | 2013 |
Ischemia-induced endothelial cell swelling and mitochondrial dysfunction are attenuated by cinnamtannin D1, green tea extract, and resveratrol in vitro.
Topics: Animals; Antioxidants; Brain Ischemia; Calcium; Cell Line; Chemokine CCL2; Cyclosporine; Egtazic Acid; Endothelial Cells; Glucose; Hypoxia; Interleukin-6; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Plant Extracts; Polyphenols; Proanthocyanidins; Reactive Oxygen Species; Resveratrol; Stilbenes; Tea; Tumor Necrosis Factor-alpha | 2015 |
Resveratrol alters human endothelial cells redox state and causes mitochondrial-dependent cell death.
Topics: Cell Death; Cell Survival; Cyclosporine; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2C9 Inhibitors; Human Umbilical Vein Endothelial Cells; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Membranes; Mitochondrial Permeability Transition Pore; Oxidative Stress; Reactive Oxygen Species; Resveratrol; Stilbenes; Sulfaphenazole | 2015 |
Polydatin protects hepatocytes against mitochondrial injury in acute severe hemorrhagic shock via SIRT1-SOD2 pathway.
Topics: Animals; Cyclosporine; Disease Models, Animal; Glucosides; Hepatocytes; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Resveratrol; Shock, Hemorrhagic; Sirtuin 1; Stilbenes; Superoxide Dismutase | 2015 |
Simple low-cost miniaturization approach for pharmaceutical nanocrystals production.
Topics: Apigenin; Ascorbic Acid; Chemistry, Pharmaceutical; Cyclosporine; Hesperidin; Miniaturization; Nanoparticles; Particle Size; Resveratrol; Stilbenes; Suspensions; Technology, Pharmaceutical | 2016 |
Evaluating the Effect of Resveratrol on the Healing of Extraction Sockets in Cyclosporine A-Treated Rats.
Topics: Animals; Cyclosporine; Female; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Tooth Extraction; Tooth Socket; Wound Healing | 2018 |
The protective effect of resveratrol against cyclosporine A-induced oxidative stress and hepatotoxicity.
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Cyclosporine; Lipid Peroxidation; Liver; Oxidative Stress; Rats; Resveratrol; Thiobarbituric Acid Reactive Substances | 2021 |
Resveratrol ameliorates the cyclosporine-induced vascular and renal impairments: possible impact of the modulation of renin-angiotensin system.
Topics: Angiotensin II; Animals; Aorta; Cyclosporine; Cytoprotection; Dose-Response Relationship, Drug; Gene Expression Regulation; Kidney; Male; NADPH Oxidase 4; Rats; Rats, Wistar; Renin-Angiotensin System; Resveratrol; RNA, Messenger; Vasoconstriction; Vasodilation | 2019 |
Resveratrol delays postovulatory aging of mouse oocytes through activating mitophagy.
Topics: Adenine; Animals; Cyclosporine; Female; Mice; Mice, Inbred ICR; Mitophagy; Oocytes; Ovulation; Resveratrol | 2019 |
Surface plasmon resonance biosensor combined with lentiviral particle stabilization strategy for rapid and specific screening of P-Glycoprotein ligands.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Products; Biosensing Techniques; Biphenyl Compounds; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cyclosporine; Cyclosporins; Dogs; Drug Evaluation, Preclinical; HEK293 Cells; Humans; In Vitro Techniques; Kinetics; Lentivirus; Ligands; Lignans; Madin Darby Canine Kidney Cells; MCF-7 Cells; Membrane Proteins; Resveratrol; Surface Plasmon Resonance | 2021 |